Last 24 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.79 | — | — | — | — | 0.88 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 54.80 | 30.03 | 15.95 | 97.36 | 28.10 | 19.42 | 10.76 | 17.87 | 0.97 | — | — | — | — | — | — | 0.35 | — | — | — | — | — |
| — | +54.7% | +48.2% | +445.0% | +2806.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | — | — | — | — | — | 1.62 | 7.46 | — | 6.82 | 5.71 | 1.09 | 0.51 | 0.33 | 0.30 | 0.29 | 0.23 | 0.91 | 1.17 | 1.02 | 2.06 | 2.00 |
| — | — | — | — | — | -71.6% | +586.6% | — | +1979.2% | +1801.3% | +279.4% | +121.9% | -64.0% | -74.3% | -72.0% | -88.8% | -54.5% | -85.5% | -79.6% | — | — | |
| P/FCF | — | — | — | — | — | — | — | 3.38 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | 1.46 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 2.52 | — | — | — | -0.04 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | +6234.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.6% | 100.0% | 98.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — | — | — | — | 100.0% | — | — | — | — | — |
| — | 0.0% | -1.3% | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | -1210.6% | -207.4% | -209.1% | -2393.8% | -1107.3% | -917.3% | -971.6% | -1311.8% | 12.3% | — | — | — | — | — | — | -17.4% | — | — | — | — | — |
| — | +77.4% | +78.5% | -82.5% | -9088.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | -6960.8% | 1003.5% | -2550.1% | -34689.2% | -7288.2% | 4043.3% | -2743.6% | -4280.8% | -14.3% | — | — | — | — | — | — | -6.2% | — | — | — | — | — |
| — | -75.2% | +7.1% | -710.4% | -50724.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | -607.2% | 150.6% | -475.3% | — | -24.5% | -139.6% | -25.9% | -21.4% | -20.8% | -15.9% | -20.6% | -1.0% | -16.0% | -14.5% | -7.5% | -12.8% | -19.1% |
| — | — | — | — | -2383.1% | +207.9% | -1732.2% | — | -17.7% | -777.9% | -26.1% | -2015.0% | -30.0% | -9.8% | -174.8% | +92.1% | +16.5% | +67.0% | +76.4% | +54.6% | +10.6% | |
| ROA | -328.9% | 42.5% | -116.2% | -190.0% | -72.8% | 36.5% | -33.0% | -58.1% | -3.1% | -61.8% | -21.3% | -17.8% | -17.7% | -13.6% | -17.5% | -0.9% | -13.7% | -12.6% | -6.2% | -10.4% | -14.8% |
| — | +16.2% | -251.8% | -226.9% | -2263.4% | +159.2% | -54.9% | -226.3% | +82.6% | -354.7% | -22.1% | -1978.9% | -29.6% | -8.2% | -180.2% | +91.8% | +7.4% | +54.9% | +72.8% | +40.4% | — | |
| ROIC | — | — | — | — | — | — | — | — | — | — | -125.6% | -70.2% | -43.5% | -24.3% | -22.5% | -2.8% | -14.8% | -12.1% | -12.1% | -14.5% | -24.6% |
| — | — | — | — | — | — | — | — | — | — | -457.9% | -2380.1% | -193.0% | -101.6% | -86.4% | +80.5% | +39.8% | +79.0% | +73.8% | +28.4% | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 0.16 | 1.40 | — | 0.27 | 0.36 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 |
| — | — | — | — | — | -55.4% | +1419.0% | — | +209.9% | +334.5% | +14.8% | +20.8% | +10.2% | +11.4% | +14.6% | +3.8% | +18.1% | -80.3% | -73.0% | -65.0% | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | 0.97 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 9.22 | 12.14 | 11.91 | 9.22 | 13.15 | 16.41 | 10.02 | 5.32 | 7.40 | 6.96 | 5.18 | 5.75 | 7.25 | 8.93 | 8.61 | 8.35 | 9.56 | 11.12 | 11.79 | 7.75 | 9.09 |
| — | -26.0% | +18.9% | +73.2% | +77.7% | +135.8% | +93.4% | -7.5% | +2.1% | -22.0% | -39.8% | -31.1% | -24.2% | -19.8% | -27.0% | +7.8% | +5.1% | +307.3% | +182.0% | +12.3% | — | |
| Quick Ratio | 9.22 | 12.14 | 11.91 | 9.22 | 13.15 | 16.41 | 10.02 | 5.32 | 7.40 | 6.96 | 5.18 | 5.75 | 7.25 | 8.93 | 8.61 | 8.35 | 9.56 | 11.12 | 11.79 | 7.75 | 9.09 |
| — | -26.0% | +18.9% | +73.2% | +77.7% | +135.8% | +93.4% | -7.5% | +2.1% | -22.0% | -39.8% | -31.1% | -24.2% | -19.8% | -27.0% | +7.8% | +5.1% | +307.3% | +182.0% | +12.3% | — | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SRZN stock.
Surrozen, Inc.'s current P/E is -0.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Surrozen, Inc.'s current operating margin is -1210.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Surrozen, Inc.'s business trajectory between earnings reports.